Literature DB >> 29580573

[Benign and malignant giant-cell rich lesions of bone: Pathological diagnosis with special emphasis on recent immunohistochemistry and molecular techniques].

Nicolas Macagno1, Kevin Caselles2, Sébastien Aubert3, Virginie Audard4, Anne Gomez-Brouchet5, Christine Galant6, Jean-Marc Guinebretière7, Marie Karanian8, Frédérique Larousserie4, Béatrice Marie9, Gonzague de Pinieux10, Corinne Bouvier2.   

Abstract

The infiltration by numerous osteoclastic giant cells is a frequent finding in bone tumors and pseudo-tumors. Pathologists must integrate clinical and radiological data to achieve a correct diagnosis in bone pathology. Benign giant-cell rich lesions of bone encompass giant cell tumor of bone, aneurysmal bone cyst, chondroblastoma, brown tumor and fibrous cortical defect/non-ossifying fibroma. Amongst malignant neoplasms, variants of conventional osteosarcoma, undifferentiated pleomorphic sarcoma, leiomyosarcoma and bone metastasis must be discussed. Recently, new diagnostic markers, antibodies for immuno-histochemistry and genetic markers, have been developed and are helpful to diagnose such lesions.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aneurysmal bone cyst; Brown tumor; Cellules géantes; Chondroblastoma; Chondroblastome; Cortical defect; Fibrome ossifiant; Giant cell tumor of bone; Giant cells; Kyste anévrysmal; Tumeur brune; Tumeur à cellules géantes des os

Mesh:

Substances:

Year:  2018        PMID: 29580573     DOI: 10.1016/j.annpat.2018.01.008

Source DB:  PubMed          Journal:  Ann Pathol        ISSN: 0242-6498            Impact factor:   0.407


  1 in total

1.  When primary hyperparathyroidism comes as good news.

Authors:  Daniela Gallo; Sara Rosetti; Ilaria Marcon; Elisabetta Armiraglio; Antonina Parafioriti; Graziella Pinotti; Giuseppe Perrucchini; Bohdan Patera; Linda Gentile; Maria Laura Tanda; Luigi Bartalena; Eliana Piantanida
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.